Insider sale reported via Form 144

Form 144 filing reports proposed sales of Common Stock related to option exercises and vested RSUs.

Rhea-AI Filing Summary

Form 144 filing reports proposed sales of Common Stock related to option exercises and vested RSUs. The filing lists 706 shares tied to an exercise of stock options dated 06/04/2026 and 4,129 shares tied to Restricted Stock Units dated 04/15/2025. The filing also records 10,282 shares sold on 04/16/2026 under a 10b5-1 plan for net proceeds of $217,155.84.

Insights

Securities Compliance Analyst

Routine Form 144 selling disclosure under Section 12 rules.

The filing documents a registered resale activity and option-related issuances: 10,282 shares were sold under a 10b5-1 arrangement on 04/16/2026, with proceeds of $217,155.84. It lists option exercises and vested RSUs as sources of shares.

These records are procedural disclosures required for public resale by insiders; cash‑flow recipients and any transfer restrictions are governed by the underlying agreements and are not detailed here. Subsequent SEC filings may show additional related transactions or clarifications.

Equity Compensation Specialist

Sale proceeds reflect exercise/vesting monetization rather than an open-market discretionary trade.

The entry for 706 shares (exercise of stock options) dated 06/04/2026 and 4,129 RSUs dated 04/15/2025 indicate exercised and vested compensation instruments are the likely source of the shares offered for resale.

Impact on dilution is informational only; the filing does not quantify outstanding share counts tied to these awards. Further filings would be needed to assess total dilution or holder-specific intent.

Key Figures

Shares sold under 10b5-1: 10,282 shares Proceeds from 10b5-1 sale: $217,155.84 Option exercise shares: 706 shares +1 more

4 metrics

Shares sold under 10b5-1 10,282 shares <date>04/16/2026</date>

Proceeds from 10b5-1 sale $217,155.84 Sale on <date>04/16/2026</date>

Option exercise shares 706 shares Exercise of stock options dated <date>06/04/2026</date>

Restricted Stock Units vested 4,129 shares Restricted Stock Units dated <date>04/15/2025</date>

Key Terms

Form 144, 10b5-1, Restricted Stock Units

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for JOHN HANNA 8000 Marina Boulevard"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 4,129 | 04/15/2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 for CDNA disclose about recent insider sales?

The filing discloses 10,282 common shares sold on 04/16/2026 under a 10b5-1 plan for $217,155.84. It also lists option exercises and vested RSUs dated 06/04/2026 and 04/15/2025 as sources.

How many shares are tied to option exercises and RSUs in the filing for CDNA?

The filing lists 706 shares associated with an exercise of stock options dated 06/04/2026 and 4,129 shares tied to Restricted Stock Units dated 04/15/2025, each shown with their corresponding dates.

Were the April 2026 insider sales for CDNA part of a trading plan?

Yes, the 10,282 shares sold on 04/16/2026 are recorded as 10b5-1 sales, indicating the transactions were executed under a pre-arranged trading plan rather than an ad hoc open-market sale.

Does the filing state who received the proceeds from the CDNA share sales?

The filing reports gross proceeds of $217,155.84 for the 10,282 shares sold on 04/16/2026. The document does not specify recipient breakdown beyond identifying the seller and the transaction method.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001781127
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAREDX, INC.
SEC File Number	001-36536
Address of Issuer	8000 Marina Boulevard, 4th Floor Brisbane CALIFORNIA 94005
Phone	4152872300
Name of Person for Whose Account the Securities are To Be Sold	JOHN WALTER HANNA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4835	107868.85	51659481	06/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/04/2026	Exercise of Stock Options	Issuer			706	06/04/2026	Cash
Common	04/15/2025	Restricted Stock Units	Issuer			4129	04/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JOHN HANNA 8000 Marina Boulevard, 4th Floor Brisbane CA 94005	Common	04/16/2026	10282	217155.84

144: Remarks and Signature

Remarks
Date of Notice	06/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ JOHN WALTER HANNA
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)